Defining Macrocytic Anemia
Macrocytic anemia is defined as anemia with a mean corpuscular volume (MCV) greater than 100 fL. 1
Laboratory Threshold
The defining criterion is straightforward and based on red blood cell size measurement:
- MCV > 100 fL is the standard threshold used in clinical practice 1
- Some sources use MCV > 98 fL as the cutoff 2
- Research settings may use MCV > 95 fL for identifying macrocytosis 3
For clinical decision-making, use MCV > 100 fL as your diagnostic threshold - this is the most widely accepted standard across multiple guidelines 1.
Classification Framework
Once macrocytic anemia is identified, classify it into two major categories:
Megaloblastic Anemia (Most Common)
- Impaired DNA synthesis causing release of large nucleated red blood cell precursors
- Primary causes:
- Drugs affecting DNA synthesis (hydroxyurea, methotrexate, azathioprine) 5
Non-Megaloblastic Anemia
- Normal DNA synthesis with various underlying causes
- Primary causes:
Clinical Significance by MCV Level
MCV > 110 fL strongly suggests megaloblastic anemia (p=0.0007), making vitamin B12 or folate deficiency highly likely 3. This higher threshold increases diagnostic specificity for nutritional deficiencies.
Important Caveats
Beware of masked macrocytosis: When microcytosis and macrocytosis coexist (e.g., combined iron deficiency and B12 deficiency), they may neutralize each other resulting in falsely normal MCV 5. In these cases, an elevated red cell distribution width (RDW) indicates the mixed population and should prompt investigation for both deficiencies 5.
Reticulocytosis creates "false macrocytosis": Reticulocytes are larger than mature red blood cells, so their increased release during hemolysis or acute hemorrhage can elevate MCV without representing true macrocytic anemia 5. Always check the reticulocyte count to distinguish this physiologic response from pathologic macrocytosis.